Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon for the prevention of postoperative delirium in cardiac surgery
2014-005370-11Phase 3Completed
- Sponsor
- UZ Leuven
- Start
- May 2015
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of xenon in postoperative delirium (POD) (2 arms), sponsored by UZ Leuven. Primary endpoint: Incidence of postoperative delirium. Started May 2015; status: completed.
02
Drugs
xenon
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on 2014-005370-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005370-11.